Mahsa Babaei

Dr. Mahsa Babaei

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
TJTahereh Jamshidnejad-tosaramandani
Tahereh Jamshidnejad-tosaramandani
SKSoheila Kashanian
Soheila Kashanian
MBMahsa Babaei
Mahsa Babaei
Mohamed Hamid Al-SabriMohamed Hamid Al-Sabri
Mohamed Hamid Al-Sabri
HSHelgi Schiöth
Helgi Schiöth
There is no definite cure for Alzheimer’s disease (AD) due to its multifactorial origin. Drugs that inhibit acetylcholinesterase (AChE), such as rivastigmine, are promising symptomatic treatments for AD. Emerging evidence suggests that insulin therapy can hinder several aspects of AD pathology. Insulin has been shown to modify the activity of AChE, but it is still unknown how insulin and AChE interact. Combination therapy, which targets several features of the disease based on existing medications, can provide a worthy therapy option for AD management. However, to date, no studies have examined the potential interaction of insulin with AChE and/or rivastigmine in vitro. In the present study, we employed the Response Surface Methodology (RSM) as an in vitro assessment to investigate the effect of insulin on both AChE activity and rivastigmine inhibitory action using a common spectrophotometric assay for cholinesterase activity, Ellman’s method. Our results showed that insulin, even at high concentrations, has an insignificant effect on both the activity of AChE and rivastigmine’s inhibitory action. The variance of our data is near zero, which means that the dispersion is negligible. However, to improve our understanding of the possible interaction of insulin and rivastigmine, or its target AChE, more in silico modelling and in vivo studies are needed.

10 May 2024 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
SMSasan Abbasi Majd
Sasan Abbasi Majd
SKSoheila Kashanian
Soheila Kashanian
ZSZahra Shekarbeygi
Zahra Shekarbeygi
MBMahsa Babaei
Mahsa Babaei

25 August 2024 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
SMSasan Abbasi Majd
Sasan Abbasi Majd
SKSoheila Kashanian
Soheila Kashanian
MBMahsa Babaei
Mahsa Babaei
ZSZahra Shekarbeygi
Zahra Shekarbeygi